Literature DB >> 29219954

Migraine with aura and persistent foramen ovale.

P T Wilmshurst1.   

Abstract

The association between migraine with aura and persistent foramen ovale (PFO), as well as other right-to-left shunts, is described. A hypothesis that might explain this association is discussed. Observational studies suggested that when a PFO is closed patients who have migraine with aura are usually improved. The Migraine Intervention with STARFlex Technology (MIST) Trial was a randomised double-blind trial in patients with severe intractable migraine with aura and a moderate-large PFO that compared implantation of STARFlex devices with the intention of closing their PFO versus a sham procedure. It was hoped that the trial would demonstrate whether PFO closure would cure migraine. A series of problems in design and execution of the trial are discussed.

Entities:  

Mesh:

Year:  2017        PMID: 29219954      PMCID: PMC5811737          DOI: 10.1038/eye.2017.269

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  27 in total

1.  5-Hydroxytryptamine; pharmacological action and destruction in perfused lungs.

Authors:  J H GADDUM; C O HEBB; A SILVER; A A SWAN
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1953

2.  Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine.

Authors:  Martijn C Post; Vincent Thijs; Luc Herroelen; Werner I H L Budts
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

3.  Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study.

Authors:  G P Anzola; M Magoni; M Guindani; L Rozzini; G Dalla Volta
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

4.  Migraine headache relief after transcatheter closure of patent foramen ovale.

Authors:  Mark Reisman; Ryan D Christofferson; Jill Jesurum; John V Olsen; Merrill P Spencer; Kimberly A Krabill; Lance Diehl; Sheena Aurora; William A Gray
Journal:  J Am Coll Cardiol       Date:  2005-02-15       Impact factor: 24.094

Review 5.  The role of cardiac and pulmonary pathology in migraine: a hypothesis.

Authors:  Peter Wilmshurst; Simon Nightingale
Journal:  Headache       Date:  2006-03       Impact factor: 5.887

6.  Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura.

Authors:  P T Wilmshurst; M J Pearson; S Nightingale; K P Walsh; W L Morrison
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

7.  Prevalence of migraine in adults with cyanotic congenital heart disease.

Authors:  Asle Hirth; Simon Nightingale; Peter Wilmshurst; Patrick Disney; Sara Thorne
Journal:  Congenit Heart Dis       Date:  2008 Mar-Apr       Impact factor: 2.007

8.  Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks.

Authors:  M Schwerzmann; S Wiher; K Nedeltchev; H P Mattle; A Wahl; C Seiler; B Meier; S Windecker
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

9.  Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.

Authors:  Andrew Dowson; Michael J Mullen; Richard Peatfield; Keith Muir; Arif Anis Khan; Christopher Wells; Susan L Lipscombe; Trevor Rees; Joseph V De Giovanni; W Lindsay Morrison; David Hildick-Smith; Giles Elrington; W Stewart Hillis; Iqbal S Malik; Anthony Rickards
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

10.  Randomised trial of prophylactic daily aspirin in British male doctors.

Authors:  R Peto; R Gray; R Collins; K Wheatley; C Hennekens; K Jamrozik; C Warlow; B Hafner; E Thompson; S Norton
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30
View more
  1 in total

Review 1.  Aura and Stroke: relationship and what we have learnt from preclinical models.

Authors:  Muge Yemisci; Katharina Eikermann-Haerter
Journal:  J Headache Pain       Date:  2019-05-29       Impact factor: 7.277

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.